Clinical Trial Update: OM336 in Seropositive Autoimmune Diseases [Phase 1]

View source ↗

Summary

Phase 1 trial update for OM336 in seropositive autoimmune diseases; the study in Sjögren's syndrome and idiopathic inflammatory myopathy is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Inflammatory Myopathy
• Sjögren Syndrome

Drugs mentioned

• OM336

Snippet

Sponsor: Ouro Medicines | Conditions: Sjogrens Disease, Idiopathic Inflammatory Myopathy (IIM) | Phase 1 | Status: NOT_YET_RECRUITING